SARS-CoV-2 (COVID-19) Full-Length Kappa Variant (B.1.617.1, India) Spike Recombinant Protein

SARS-CoV-2 (COVID-19) Spike Recombinant Protein: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein

This recombinant protein can be used for ELISA assays, Ligand binding assays (e.g. SPR), Biochemical and biophysical analyses. For research use only.

All viruses undergo fast mutations and adapt quickly to the countermeasures that the immune systems creates. SARS-CoV-2 of the COVID-19 pandemic is no exception to this. During the pandemic multiple mutant strains arose. To help the sciencific community to combat these mutants ProSci offers the SPIKE protein of the mutants in full-length and active in their native trimeric form, stabilized with the LMNG detergent. This is the spike protein of the mutant strain B.1.429, also known as mutant strain CAL.20C or "California mutant".

not determined

20 mM Hepes pH 7.5; 150 mM NaCl, 0.001 % LMNG

batch dependent

C-terminal Rho1D4

43740568

surface glycoprotein

S

Severe acute respiratory syndrome coronavirus 2

Liquid

1286 amino acids (including Rho1D4 tag and linker); 142115.37 Da

>98% as determined by SDS-PAGE, see Fig. 1 A and B. PureCube Rho1D4 Agarose.

#N/A

HEK293 cells

P0DTC2